<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-JY41DPCZ</identifier><date>2016</date><creator>Fortuna, Krištof</creator><relation>documents/doc/J/URN_NBN_SI_doc-JY41DPCZ_001.pdf</relation><relation>documents/doc/J/URN_NBN_SI_doc-JY41DPCZ_001.txt</relation><format format_type="issue">1</format><format format_type="volume">79</format><format format_type="type">article</format><format format_type="extent">str. 19-28, 46-47</format><identifier identifier_type="ISSN">0033-1805</identifier><identifier identifier_type="COBISSID">4183921</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-JY41DPCZ</identifier><language>slv</language><publisher>Prirodoslovno društvo Slovenije</publisher><source>Proteus</source><rights>InC</rights><subject language_type_id="slv">biokemija</subject><subject language_type_id="slv">encimi</subject><subject language_type_id="slv">encimologija</subject><subject language_type_id="slv">encimske reakcije</subject><subject language_type_id="slv">farmacija</subject><subject language_type_id="slv">inhibitorji</subject><subject language_type_id="slv">katepsin X</subject><subject language_type_id="slv">zaviralna aktivnost</subject><title>Encimi - obetavne tarče za razvoj novih zdravil</title></Record>